Assessment of potential drug–drug interactions in cancer patients in a tertiary care hospital

Indian Journal of Cancer · Published 2025-04-01 · DOI 10.4103/ijc.ijc_24_23

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.4103/ijc.ijc_24_23

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• An interinstitutional treatment outcomes comparison for oral cavity cancers from two tertiary care centers · Indian Journal of Cancer · 2026 · Same journal
• District cancer control program: A white paper to optimize cancer care in rural India by developing a uniform, modular, and multi-tier system · Indian Journal of Cancer · 2026 · Same journal
• Leiomyomatosis peritonealis disseminata associated with large uterine myoma without history of surgery: A case report and review of literature · Indian Journal of Cancer · 2025 · Same journal
• Olaparib and temozolomide combination in relapsed metastatic Ewing sarcoma brings a new ray of hope · Indian Journal of Cancer · 2025 · Same journal
• Primary undifferentiated pleomorphic sarcoma of biceps femoris · Indian Journal of Cancer · 2025 · Same journal
• Bladder preserving approach for treatment of primary osteogenic sarcoma of bladder: A rare case report · Indian Journal of Cancer · 2025 · Same journal
• Succinate dehydrogenase deficient GIST: Case series and review of literature from a tertiary care center in India · Indian Journal of Cancer · 2025 · Same journal
• Radiation-induced lung injury due to extra thoracic irradiation · Indian Journal of Cancer · 2025 · Same journal
• Monoclonal antibodies in 2025: From milestones to new frontiers · Indian Journal of Cancer · 2025 · Same journal
• Primary pure angiosarcoma of the ovary: A case report · Indian Journal of Cancer · 2025 · Same journal